Research
Recent Publications
A Receptor Story: Insulin Resistance Pathophysiology and Physiologic Insulin Resensitization’s Role as a Treatment Modality
Physiologic hormone administration improves HbA1C in Native Americans with type 2 diabetes: A retrospective study and review of insulin secretion and action
Case Series: Reversal of Diabetic Retinopathy in two Patients Following the use of Physiologic Insulin Resensitization
Efficacy of Physiologic Insulin Resensitization as a Treatment for Insulin Resistance Pathophysiology
Efficacy of Physiologic Insulin Resensitization as a Treatment for Insulin Resistance Pathophysiology
Other Publications
“Economic Costs of Diabetes in the U.S. 2017” (Published online in Diabetes Care Mar, 2018)
Per Brian Loveridge, MD; “Diabetes represents the most expensive medical condition in America. The prevalence continues to rise, with one out of two adults having either diabetes or pre-diabetes. Greater focus and attention is needed to address the complications of this epidemic that plagues both the U.S., and the world at large. We want to be a part of the solution with our physiologic insulin treatments.”